{"success":true,"data":{"_id":141888535,"filings":[{"Organization":{"Hours":[0],"Total Compensation":[0],"Direct compensation":[0],"Other compensation":[0]},"Basic":{"mission":"The primary immunodeficiency research consortium was established to advance scientific research in the primary immune deficiency diseases (pidd).","primary_activities":"Activity classification: liquidation. Grantee name: immune deficiency foundation. Grantee address: 40 west chesapeake avenue towson, md 21204. Grantee relationship: related organization. Property description: cash. Method used to determine book value: cash value . Method used to determine fmv: cash value. Book value of property: 159,536. Date of gift: 07/17/13. Amount given: 159,536.\n\nDescription: computer/registry upgrades. Amount: 1,730. Description: travel. Amount: 3,224. Description: meetings. Amount: 32,685. Description: awards. Amount: 9,044. Description: supplies. Amount: 4,975. Description: enrollment. Amount: 816. Total to form 990-ez, line 16: 52,474.","year":2012,"name":"PRIMARY IMMUNODEFICIENCY RESEARCH CONSORTIUM INC","phone":"4103216647","website":"WWW.USIDNET.ORG","type":"990EZ","tax_period_begin":"2013-01-01T00:00:00","tax_period_end":"2013-07-17T00:00:00","address":"40 WEST CHESAPEAKE AVE NO 308, TOWSON, MD, 21204, USA","city":"TOWSON","state":"MD","country":"USA","zip_code":"21204"},"Governance":{"501c3 determination":true},"Revenues":{"value":7000},"Expenses":{"value":212010,"Grant expense":{"value":159536,"Grants and similar":159536},"Other expenses":{"value":52474,"Itemized Expenses":52474},"Functional Expenses":{"Program Service Expenses":212010}},"Fund balance":{"value":0},"Form990Details":{"officers_directors_key_employees":[{"person_name":"MARCIA L BOYLE","title":"PRESIDENT","average_hours_per_week_devoted_to_position":2.0,"compensation":0,"employee_benefit_contributions":0,"expense_account_allowances":0,"name":"MARCIA L BOYLE"},{"person_name":"HANS D OCHS","title":"DIRECTOR","average_hours_per_week_devoted_to_position":0.0,"compensation":0,"employee_benefit_contributions":0,"expense_account_allowances":0,"name":"HANS D OCHS"},{"person_name":"CHARLOTTE CUNNINGHAM-RUN","title":"DIRECTOR","average_hours_per_week_devoted_to_position":1.0,"compensation":0,"employee_benefit_contributions":0,"expense_account_allowances":0,"name":"CHARLOTTE CUNNINGHAM-RUN"},{"person_name":"SARAH ROSE","title":"DIRECTOR OF FINANCE","average_hours_per_week_devoted_to_position":0.5,"compensation":0,"employee_benefit_contributions":0,"expense_account_allowances":0,"name":"SARAH ROSE"}]},"ScheduleA":{"public_charity_status":{"publicly_supported_org_170b1_avi":true},"support_170":{"thirty_three_percent_test_current_year":true,"gifts_grants_contributions":{"value":1631352,"current_year_minus2":75000,"current_year_minus3":359520,"current_year_minus4":1196832},"total_calendar_year_support":{"value":1631352,"current_year_minus2":75000,"current_year_minus3":359520,"current_year_minus4":1196832},"gross_receipts_from_admissions_etc":35000,"amounts_from_substantial_contributors":117314,"public_support_total":1514038,"gross_investment_income":{"value":1161,"current_year_minus4":1161},"other_income":{"value":1788,"current_year_minus4":1788},"total_support":1634301,"public_support_percentage":0.9264},"supplemental_information":{"general":{"explanation":"SCHEDULE A, PART IV, SUPPLEMENTAL INFORMATION: PRIMARY IMMUNODEFICIENCY RESEARCH CONSORTIUM, INC. HAD A SHORT YEAR DUE TO THE DISSOLUTION OF THE CORPORATION. THE 2012 COLUMN INCLUDES THE ACTIVITY FROM THE SHORT PERIOD JANUARY 1, 2013 TO JULY 17, 2013. THE 2011 COLUMN INCLUDES THE ACTIVITY FROM THE YEAR ENDED DECEMBER 31, 2012. THE 2010 COLUMN INCLUDES THE ACTIVITY FROM THE YEAR ENDED DECEMBER 31, 2011. THE 2009 COLUMN INCLUDES THE ACTIVITY FROM THE YEAR ENDED DECEMBER 31, 2010. THE 2008 COLUMN INCLUDES THE ACTIVITY FROM THE YEAR ENDED DECEMBER 31, 2009."}}},"ScheduleB":{"attached":false},"ScheduleN":{"termination_or_liquidation":{"assets_distributed":true,"liabilities_paid":true,"bonds_outstanding":false,"required_to_notify_attorney_general":true,"attorney_general_notified":true},"successor_relationships":{"director_of_successor":true,"employee_of_successor":true,"owner_of_successor":false},"liquidations":[{"business_name_line1":"IMMUNE DEFICIENCY FOUNDATION","ein":521214782,"irc_section":"501(C)(3)","distribution_date":"2013-07-17T00:00:00","description":"CASH","fair_market_value":159536,"method_of_fmv_determination":"BOOK VALUE","address_line1":"40 WEST CHESAPEAKE AVENUE","city":"TOWSON","state":"MD","zip":"21204","name":"IMMUNE DEFICIENCY FOUNDATION","address":"40 WEST CHESAPEAKE AVENUE, TOWSON, MD, 21204"}],"supplemental_information":[{"explanation":"PART I, LINE 2E: MARCIA BOYLE, SARAH ROSE"},{"explanation":"PART I, LINE 2E: MARCIA BOYLE WAS THE PRESIDENT OF PIRC AND IS THE PRESIDENT/CHAIR OF IMMUNE DEFICIENCY FOUNDATION.MARCIA BOYLE AND SARAH ROSE WERE OFFICERS OF PIRC AND ARE EMPLOYEES OF IMMUNE DEFICIENCY FOUNDATION."}]},"source_xml":"201303409349200100_public.xml"},{"Organization":{"Hours":[0],"Total Compensation":[0],"Direct compensation":[0],"Other compensation":[0]},"Basic":{"mission":"To advance scientific research in the primary immune deficiency diseases. Pirc was formed to provide a variety of services including, but not limited to research grants associated with pidd, a pidd patient registry, education and mentoring and a repositoryfor pidd cell lines.","primary_activities":"Continue to redesign and amplify the scope and work of existing patient data registries.\n\nEstablish a multifacited mentoring program to introduce investigators new to the field and stimulate interest and research in primary immune deficiency diseases.","year":2010,"name":"PRIMARY IMMUNODEFICIENCY RESEARCH CONSORTIUM INC","phone":"4103216647","website":"WWW.USIDNET.ORG","type":"990","principal_officer":"MARCIA L BOYLE","year_formation":2002,"state_legal_domicile":"MD","total_volunteers":0,"tax_period_begin":"2010-01-01T00:00:00","tax_period_end":"2010-12-31T00:00:00","address":"40 WEST CHESAPEAKE AVE NO 308, TOWSON, MD, 21204, USA","city":"TOWSON","state":"MD","country":"USA","zip_code":"21204"},"Governance":{"501c3 determination":true,"Number of voting members":3,"Number of independent voting members":2,"Number of employees total":0,"Total Gross UBI":0,"Net unrelated business taxable income":0,"Number of employees":0,"Prohibited tax shelter transactions":false,"Taxable party notification":false,"Funds to pay premiums":false,"Premiums Paid":false,"Family or business relationship":false,"Delegation of management duties":true,"Conflict of interest policy":false,"Whistle blower policy":false,"Compensation process for CEO":true,"Compensation process for other employees":false,"Changes to organizing documents":false,"Material diversion or misuse":false,"Members or stockholders":false,"Election of board members":false,"Decisions subject to approval":false,"Minutes of governing body":true,"Local chapters":false,"Form 990 provided to governing body":true,"Document retention policy":true,"Investment in joint venture":false,"Independent audit financial statements":false,"Consolidated audit financial statements":true,"Accountant compile or review":false,"Financial statements audited by independent accountant":true,"Audit committee":true,"Federal grant audit required":false,"Political activities":false,"Donor advised funds":false,"Conservation easements":false,"Collections of art":false,"School":false,"Hospital":false,"Foreign activities":false,"Foreign office":false,"Gaming":false,"Fundraising activities":false,"Professional fundraising":false,"Loan to officer or DQP":false,"Grant to related person":false,"Business relationship through family member":false,"Business relationship with organization":false,"Transfers to exempt non-charitable organization":false},"Revenues":{"value":359520,"Contributions":{"value":0},"Program revenue":{"value":359520,"Total revenue":359520,"Unrelated business revenue":0},"Investment income":{"value":0},"Other revenues":{"value":0}},"Expenses":{"value":294768,"Grant expense":{"value":0},"Total professional fundraising expense":{"value":0},"Benefits paid to members":{"value":0},"Salaries":{"value":0},"Other expenses":{"value":294768,"Other services":191239,"Office expenses":1847,"Travel":19086,"Conferences and meetings":5304,"Itemized Expenses":77292}},"Assets":{"value":149068,"Savings and temp cash investments":146468,"Accounts receivable":2600},"Liabilities":{"value":2600,"Other liabilities":2600},"Fund balance":{"value":146468},"Form990Details":{"program_service_accomplishments":[{"description":"CONTINUE TO REDESIGN AND AMPLIFY THE SCOPE AND WORK OF EXISTING PATIENT DATA REGISTRIES.","expense":219676},{"description":"ESTABLISH A MULTIFACITED MENTORING PROGRAM TO INTRODUCE INVESTIGATORS NEW TO THE FIELD AND STIMULATE INTEREST AND RESEARCH IN PRIMARY IMMUNE DEFICIENCY DISEASES.","expense":75092,"revenue":359520}],"program_service_revenue_detail":[{"business_code":"541700","description":"RESEARCH CONTRACT REVE","total_revenue":359520,"related_or_exempt_function_income":359520}],"functional_expense_allocations":{"other_service_fees":{"program_services":191239,"total":191239},"office_expenses":{"program_services":1847,"total":1847},"travel":{"program_services":19086,"total":19086},"conferences_meetings":{"program_services":5304,"total":5304}},"tax_and_disclosure_flags":{"activities_conducted_through_partnership":false,"foreign_financial_account":false,"backup_withholding_compliance":true,"lobbying_activities":false,"deductible_non_cash_contributions":false,"deductible_contributions_of_art":false,"method_of_accounting_accrual":true,"schedule_o_part_vi":true,"schedule_o_part_vii":true},"principal_officer_detail":{"person_name":"MARCIA L BOYLE","address_line1":"40 WEST CHESAPEAKE AVE NO 308","city":"TOWSON","state":"MD","zip":"21204"},"audit_financial_statement_detail":{"accountant_compile_or_review":false,"audited_financial_statement_consolidated":true,"federal_grant_audit_required":false},"related_party_due_diligence":{"officer_entity_with_business_relationship":false,"officer_mailing_address":false,"related_entity":true,"related_org_controlled_entity":false,"compensation_from_other_sources":false,"excess_benefit_transaction":false},"grant_due_diligence":{"grants_to_organizations":false,"grants_to_individuals":false,"more_than_5000_to_organizations":false,"more_than_5000_to_individuals":false},"books_are_in_care_of":{"phone":"4103216647","business_name_line1":"LEIGH PROFIT","address_line1":"40 WEST CHESAPEAKE AVE SUITE 308","city":"TOWSON","state":"MD","zip":"21204"},"officers_directors_key_employees":[{"title":"PRESIDENT/DIRECTOR","average_hours_per_week":2.0,"reportable_comp_from_org":0,"reportable_comp_from_related_orgs":196525,"other_compensation":23106,"individual_trustee_or_director":true,"officer":true},{"title":"DIRECTOR","average_hours_per_week":2.0,"reportable_comp_from_org":0,"reportable_comp_from_related_orgs":0,"other_compensation":0,"individual_trustee_or_director":true},{"title":"DIRECTOR","average_hours_per_week":2.0,"reportable_comp_from_org":0,"reportable_comp_from_related_orgs":0,"other_compensation":0,"individual_trustee_or_director":true},{"title":"DIRECTOR OF FINANCE","average_hours_per_week":5.0,"reportable_comp_from_org":0,"reportable_comp_from_related_orgs":113707,"other_compensation":21023,"officer":true}]},"ScheduleA":{"public_charity_status":{"publicly_supported_org_170b1_avi":true},"support_170":{"thirty_three_percent_test_current_year":true,"gifts_grants_contributions":{"value":150000,"current_year_minus1":75000,"current_year_minus2":75000},"total_calendar_year_support":{"value":150000,"current_year_minus1":75000,"current_year_minus2":75000},"gross_receipts_from_admissions_etc":11322446,"public_support_total":150000,"gross_investment_income":{"value":25778,"current_year_minus1":1161,"current_year_minus2":4400,"current_year_minus3":9627,"current_year_minus4":10590},"other_income":{"value":1788,"current_year_minus1":1788},"total_support":177566,"public_support_percentage":0.8448}},"ScheduleB":{"attached":false,"required":false},"ScheduleD":{"endowment_funds":{"current_year":{"beginning_year_balance":14795,"investment_earnings_or_losses":1418,"end_year_balance":16213},"current_year_minus1":{"contributions":14795,"end_year_balance":14795},"permanent_endowment_eoy_percentage":1.0,"held_by_unrelated_organizations":false,"held_by_related_organizations":true,"related_organizations_listed_schedule_r":true},"land_buildings_equipment":{"total_book_value":0},"other_liabilities":{"liabilities":[{"description":"DUE TO IDF","amount":2600}],"total_liability":2600},"net_assets_reconciliation":{"total_revenue":359520,"total_expenses":294768,"excess_or_deficit_for_year":64752,"total_adjustments":0,"excess_or_deficit_per_financial_statements":64752},"revenue_reconciliation":{"total_revenue_audited_financial_statements":4825876,"other_revenue":4520955,"revenue_not_reported":4520955,"revenue_subtotal":304921,"other_revenues_not_included":54599,"revenue_not_reported_financial_statement":54599,"total_revenue_per_990":359520},"expense_reconciliation":{"total_expenses_audited_financial_statements":4646372,"other_expenses_included":4406203,"expenses_not_reported":4406203,"expenses_subtotal":240169,"other_expenses_not_included":54599,"expenses_not_reported_financial_statement":54599,"total_expenses_per_990":294768},"supplemental_information":[{"identifier":"DESCRIPTION OF INTENDED USE OF ENDOWMENT FUNDS:","explanation":"THE ENDOWMENT FUND IS HELD BY THE IMMUNE DEFICIENCY FOUNDATION, A RELATED 501(C)(3) ORGANIZATION. THE ENDOWMENT IS FUNDED BY EITHER OR BOTH OF THE ANNUAL CONTRIBUTIONS MADE TO THE SCHOLARSHIP PROGRAM THAT EXCEED THE FUNDS NECESSARY TO SUPPORT THE SCHOLARSHIPS AWARDED EACH YEAR; AND CONTRIBUTIONS AND MONIES GENERATED BY FUNDRAISING EVENTS THAT ARE SPECIALLY DESIGNATED AS FUNDS ALLOCATED FOR THE ENDOWMENT. THE INVESTMENT RETURN GOAL IS TO GENERATE A 5% TO 8% ANNUAL RETURN WHILE INVESTED IN CONSERVATIVE INVESTMENT INSTRUMENTS. NO DISTRIBUTIONS SHALL BE MADE FROM THE ENDOWMENT UNTIL THE ENDOWMENT HAS ATTAINED A BALANCE OF $100,000. ONCE THE ENDOWMENT ATTAINS A BALANCE OF $100,000 DISTRIBUTIONS OF 5% OF THE ENDOWMENT BALANCE MAY BE MADE TO THE SCHOLARSHIP PROGRAM."},{"identifier":"DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48:","explanation":"PIRC HAS ADOPTED THE ACCOUNTING STANDARD ON ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES, WHICH ADDRESSES THE DETERMINATION OF WHETHER TAX BENEFITS CLAIMED OR EXPECTED TO BE CLAIMED ON A TAX RETURN SHOULD BE RECORDED IN THE FINANCIAL STATEMENTS. UNDER THIS GUIDANCE, PIRC MAY RECOGNIZE THE TAX BENEFIT FROM AN UNCERTAIN TAX POSITION ONLY IF IT'S MORE-THAN-LIKELY-THAN-NOT THAT THE TAX POSITION WILL BE SUSTAINED ON EXAMINATION BY TAXING AUTHORITIES, BASED ON THE TECHNICAL MERITS OF THE POSITION. THE GUIDANCE ON ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES ALSO ADDRESSES DE-RECOGNITION CLASSIFICATION, INTEREST,AND PENALTIES ON INCOME TAXES, AND ACCOUNTING IN INTERIM PERIODS. MANAGEMENT HAS EVALUATED THE FOUNDATION'S TAX POSITIONS AND HAS CONCLUDED THAT PIRC HAS TAKEN NO UNCERTAIN TAX POSITIONS THAT REQUIRE ADJUSTMENT TO THE CONSOLIDATED FINANCIAL STATEMENTS TO COMPLY WITH THE PROVISION OF THIS GUIDANCE. WITH FEW EXCEPTIONS, PIRC IS NO LONGER SUBJECT TO U.S. FEDERAL, STATE AND LOCAL INCOME TAX EXAMINATIONS BY TAX AUTHORITY FOR THE YEARS ENDING DECEMBER 31, 2007."},{"identifier":"PART XII, LINE 2D - OTHER ADJUSTMENTS:","explanation":"REVENUE OF IDF INCLUDED ON CONSOLIDATED FINANCIAL STATEMENTS 4,520,955."},{"identifier":"PART XII, LINE 4B - OTHER ADJUSTMENTS:","explanation":"REVENUE ELIMINATED ON CONSOLIDATED FINANCIAL STATEMENTS 54,599."},{"identifier":"PART XIII, LINE 2D - OTHER ADJUSTMENTS:","explanation":"EXPENSES OF IDF INCLUDED ON CONSOLIDATED FINANCIAL STATEMENTS 4,406,203."},{"identifier":"PART XIII, LINE 4B - OTHER ADJUSTMENTS:","explanation":"EXPENSES ELIMINATED ON CONSOLIDATED FINANCIAL STATEMENTS 54,599."}]},"ScheduleJ":{"compensation_arrangements":{"compensation_based_on_revenue_filing_org":false,"compensation_based_on_revenue_related_orgs":false,"compensation_based_on_net_earnings_filing_org":false,"compensation_based_on_net_earnings_related_orgs":false,"nonfixed_payments":false,"initial_contract_exception":false,"severance_payment":false,"supplemental_nonqualified_retirement_plan":false,"equity_based_compensation_arrangement":false},"compensation":[{"person_name":"MARCIA L BOYLE","base_compensation_filing_org":0,"bonus_filing_org":0,"bonus_related_orgs":0,"compensation_based_on_related_orgs":196525,"comp_report_prior_990_filing_org":0,"comp_report_prior_990_related_orgs":0,"deferred_compensation_filing_org":0,"deferred_compensation_related_orgs":8000,"nontaxable_benefits_filing_org":0,"nontaxable_benefits_related_orgs":15106,"other_compensation_filing_org":0,"other_compensation_related_orgs":0,"total_compensation_filing_org":0,"total_compensation_related_orgs":219631,"name":"MARCIA L BOYLE"}],"supplemental_information":[{"identifier":"SUPPLEMENTAL INFORMATION","form_and_line_reference":"PART III","explanation":"SCHEDULE J, PART I, LINE 3 IMMUNE DEFICIENCY FOUNDATION, A RELATED ORGANIZATION, ESTABLISHES THE COMPENSATION OF THE PRESIDENT. THE FOUNDATION USES A COMPENSATION COMMITTEE AND APPROVAL BY THE BOARD OR COMPENSATION COMMITTEE."}]},"ScheduleR":{"tax_exempt_organizations":[{"ein":521214782,"business_name_line1":"IMMUNE DEFICIENCY FOUNDATION INC","primary_activities":"PROMOTE & SUPPORT SCIENTIFIC RESEARCH","exempt_code_section":"501(C)(3)","public_charity_status":"7","controlled_organization":false,"legal_domicile_state":"DE","address_line1":"40 WEST CHSAPEAKE AVENUE NO 308","city":"TOWSON","state":"MD","zip":"21204","name":"IMMUNE DEFICIENCY FOUNDATION INC","address":"40 WEST CHSAPEAKE AVENUE NO 308, TOWSON, MD, 21204"}],"transaction_flags":{"gift_grant_or_capital_contribution_from_other_org":false,"gift_grant_or_capital_contribution_to_other_org":false,"loans_or_guarantees_from_other_org":true,"loans_or_guarantees_to_other_org":false,"performance_of_services_by_other_orgs":false,"performance_of_services_for_other_orgs":false,"sharing_of_facilities":true,"sharing_of_paid_employees":true,"reimbursement_paid_by_other_org":false,"reimbursement_paid_to_other_org":true,"rental_of_facilities_from_other_orgs":false,"rental_of_facilities_to_other_orgs":false,"purchase_of_assets_from_other_org":false,"sale_of_assets_to_other_org":false,"exchange_of_assets":false,"receipt_of_interest_annuities_rents_royalties":false,"other_transfer_from_other_org":false,"other_transfer_to_other_org":false}},"source_xml":"201113199349305636_public.xml"},{"Organization":{"Hours":[0],"Total Compensation":[0],"Direct compensation":[0],"Other compensation":[0]},"Basic":{"mission":"The primary immunodeficiency research consortium was established to advance scientific research in the primary immune deficiency diseases (pidd).","primary_activities":"Description: aaaai expenses. Amount: 14,675. Description: travel. Amount: 422. Description: meetings. Amount: 573. Description: awards. Amount: 4,315. Total to form 990-ez, line 16: 19,985.","year":2011,"name":"PRIMARY IMMUNODEFICIENCY RESEARCH CONSORTIUM INC","phone":"4103216647","website":"WWW.USIDNET.ORG","type":"990EZ","tax_period_begin":"2011-01-01T00:00:00","tax_period_end":"2011-12-31T00:00:00","address":"40 WEST CHESAPEAKE AVE NO 308, TOWSON, MD, 21204, USA","city":"TOWSON","state":"MD","country":"USA","zip_code":"21204"},"Governance":{"501c3 determination":true},"Revenues":{"value":96000,"Contributions":{"value":75000,"Contributions from gifts and grants":75000}},"Expenses":{"value":35349,"Total professional fundraising expense":{"value":14162,"Fees to independent contractors":14162},"Other expenses":{"value":21187,"Printing, publications, postage":1202,"Itemized Expenses":19985},"Functional Expenses":{"Program Service Expenses":35349}},"Fund balance":{"value":205009},"Form990Details":{"officers_directors_key_employees":[{"person_name":"MARCIA L BOYLE","title":"PRESIDENT","average_hours_per_week_devoted_to_position":2.0,"compensation":0,"employee_benefit_contributions":0,"expense_account_allowances":0,"address_line1":"40 WEST CHESAPEAKE AVENUE 308","city":"TOWSON","state":"MD","zip":"21204","name":"MARCIA L BOYLE","address":"40 WEST CHESAPEAKE AVENUE 308, TOWSON, MD, 21204"},{"person_name":"HANS D OCHS","title":"DIRECTOR","average_hours_per_week_devoted_to_position":2.0,"compensation":0,"employee_benefit_contributions":0,"expense_account_allowances":0,"address_line1":"40 WEST CHESAPEAKE AVENUE 308","city":"TOWSON","state":"MD","zip":"21204","name":"HANS D OCHS","address":"40 WEST CHESAPEAKE AVENUE 308, TOWSON, MD, 21204"},{"person_name":"CHARLOTTE CUNNINGHAM-RUN","title":"DIRECTOR","average_hours_per_week_devoted_to_position":2.0,"compensation":0,"employee_benefit_contributions":0,"expense_account_allowances":0,"address_line1":"40 WEST CHESAPEAKE AVENUE 308","city":"TOWSON","state":"MD","zip":"21204","name":"CHARLOTTE CUNNINGHAM-RUN","address":"40 WEST CHESAPEAKE AVENUE 308, TOWSON, MD, 21204"},{"person_name":"DEBRA ADLIS","title":"DIRECTOR OF FINANCE","average_hours_per_week_devoted_to_position":5.0,"compensation":0,"employee_benefit_contributions":0,"expense_account_allowances":0,"address_line1":"40 WEST CHESAPEAKE AVENUE 308","city":"TOWSON","state":"MD","zip":"21204","name":"DEBRA ADLIS","address":"40 WEST CHESAPEAKE AVENUE 308, TOWSON, MD, 21204"},{"person_name":"LEIGH PROFIT","title":"DIRECTOR OF FINANCE","average_hours_per_week_devoted_to_position":5.0,"compensation":0,"employee_benefit_contributions":0,"expense_account_allowances":0,"address_line1":"40 WEST CHESAPEAKE AVENUE 308","city":"TOWSON","state":"MD","zip":"21204","name":"LEIGH PROFIT","address":"40 WEST CHESAPEAKE AVENUE 308, TOWSON, MD, 21204"}]},"ScheduleA":{"public_charity_status":{"publicly_supported_org_170b1_avi":true},"support_170":{"thirty_three_percent_test_current_year":true,"gifts_grants_contributions":{"value":8049547,"current_year":75000,"current_year_minus1":359520,"current_year_minus2":1196832,"current_year_minus3":3911956,"current_year_minus4":2506239},"total_calendar_year_support":{"value":8049547,"current_year":75000,"current_year_minus1":359520,"current_year_minus2":1196832,"current_year_minus3":3911956,"current_year_minus4":2506239},"gross_receipts_from_admissions_etc":21000,"amounts_from_substantial_contributors":63670,"public_support_total":7985877,"gross_investment_income":{"value":15188,"current_year_minus2":1161,"current_year_minus3":4400,"current_year_minus4":9627},"other_income":{"value":1788,"current_year_minus2":1788},"total_support":8066523,"public_support_percentage":0.99}},"ScheduleB":{"attached":true},"source_xml":"201232759349200203_public.xml"}],"Latest":{"Organization":{"Hours":[0],"Total Compensation":[0],"Direct compensation":[0],"Other compensation":[0]},"Basic":{"mission":"The primary immunodeficiency research consortium was established to advance scientific research in the primary immune deficiency diseases (pidd).","primary_activities":"Activity classification: liquidation. Grantee name: immune deficiency foundation. Grantee address: 40 west chesapeake avenue towson, md 21204. Grantee relationship: related organization. Property description: cash. Method used to determine book value: cash value . Method used to determine fmv: cash value. Book value of property: 159,536. Date of gift: 07/17/13. Amount given: 159,536.\n\nDescription: computer/registry upgrades. Amount: 1,730. Description: travel. Amount: 3,224. Description: meetings. Amount: 32,685. Description: awards. Amount: 9,044. Description: supplies. Amount: 4,975. Description: enrollment. Amount: 816. Total to form 990-ez, line 16: 52,474.","year":2012,"name":"PRIMARY IMMUNODEFICIENCY RESEARCH CONSORTIUM INC","phone":"4103216647","website":"WWW.USIDNET.ORG","type":"990EZ","tax_period_begin":"2013-01-01T00:00:00","tax_period_end":"2013-07-17T00:00:00","address":"40 WEST CHESAPEAKE AVE NO 308, TOWSON, MD, 21204, USA","city":"TOWSON","state":"MD","country":"USA","zip_code":"21204"},"Governance":{"501c3 determination":true},"Revenues":{"value":7000},"Expenses":{"value":212010,"Grant expense":{"value":159536,"Grants and similar":159536},"Other expenses":{"value":52474,"Itemized Expenses":52474},"Functional Expenses":{"Program Service Expenses":212010}},"Fund balance":{"value":0},"Form990Details":{"officers_directors_key_employees":[{"person_name":"MARCIA L BOYLE","title":"PRESIDENT","average_hours_per_week_devoted_to_position":2.0,"compensation":0,"employee_benefit_contributions":0,"expense_account_allowances":0,"name":"MARCIA L BOYLE"},{"person_name":"HANS D OCHS","title":"DIRECTOR","average_hours_per_week_devoted_to_position":0.0,"compensation":0,"employee_benefit_contributions":0,"expense_account_allowances":0,"name":"HANS D OCHS"},{"person_name":"CHARLOTTE CUNNINGHAM-RUN","title":"DIRECTOR","average_hours_per_week_devoted_to_position":1.0,"compensation":0,"employee_benefit_contributions":0,"expense_account_allowances":0,"name":"CHARLOTTE CUNNINGHAM-RUN"},{"person_name":"SARAH ROSE","title":"DIRECTOR OF FINANCE","average_hours_per_week_devoted_to_position":0.5,"compensation":0,"employee_benefit_contributions":0,"expense_account_allowances":0,"name":"SARAH ROSE"}]},"ScheduleA":{"public_charity_status":{"publicly_supported_org_170b1_avi":true},"support_170":{"thirty_three_percent_test_current_year":true,"gifts_grants_contributions":{"value":1631352,"current_year_minus2":75000,"current_year_minus3":359520,"current_year_minus4":1196832},"total_calendar_year_support":{"value":1631352,"current_year_minus2":75000,"current_year_minus3":359520,"current_year_minus4":1196832},"gross_receipts_from_admissions_etc":35000,"amounts_from_substantial_contributors":117314,"public_support_total":1514038,"gross_investment_income":{"value":1161,"current_year_minus4":1161},"other_income":{"value":1788,"current_year_minus4":1788},"total_support":1634301,"public_support_percentage":0.9264},"supplemental_information":{"general":{"explanation":"SCHEDULE A, PART IV, SUPPLEMENTAL INFORMATION: PRIMARY IMMUNODEFICIENCY RESEARCH CONSORTIUM, INC. HAD A SHORT YEAR DUE TO THE DISSOLUTION OF THE CORPORATION. THE 2012 COLUMN INCLUDES THE ACTIVITY FROM THE SHORT PERIOD JANUARY 1, 2013 TO JULY 17, 2013. THE 2011 COLUMN INCLUDES THE ACTIVITY FROM THE YEAR ENDED DECEMBER 31, 2012. THE 2010 COLUMN INCLUDES THE ACTIVITY FROM THE YEAR ENDED DECEMBER 31, 2011. THE 2009 COLUMN INCLUDES THE ACTIVITY FROM THE YEAR ENDED DECEMBER 31, 2010. THE 2008 COLUMN INCLUDES THE ACTIVITY FROM THE YEAR ENDED DECEMBER 31, 2009."}}},"ScheduleB":{"attached":false},"ScheduleN":{"termination_or_liquidation":{"assets_distributed":true,"liabilities_paid":true,"bonds_outstanding":false,"required_to_notify_attorney_general":true,"attorney_general_notified":true},"successor_relationships":{"director_of_successor":true,"employee_of_successor":true,"owner_of_successor":false},"liquidations":[{"business_name_line1":"IMMUNE DEFICIENCY FOUNDATION","ein":521214782,"irc_section":"501(C)(3)","distribution_date":"2013-07-17T00:00:00","description":"CASH","fair_market_value":159536,"method_of_fmv_determination":"BOOK VALUE","address_line1":"40 WEST CHESAPEAKE AVENUE","city":"TOWSON","state":"MD","zip":"21204","name":"IMMUNE DEFICIENCY FOUNDATION","address":"40 WEST CHESAPEAKE AVENUE, TOWSON, MD, 21204"}],"supplemental_information":[{"explanation":"PART I, LINE 2E: MARCIA BOYLE, SARAH ROSE"},{"explanation":"PART I, LINE 2E: MARCIA BOYLE WAS THE PRESIDENT OF PIRC AND IS THE PRESIDENT/CHAIR OF IMMUNE DEFICIENCY FOUNDATION.MARCIA BOYLE AND SARAH ROSE WERE OFFICERS OF PIRC AND ARE EMPLOYEES OF IMMUNE DEFICIENCY FOUNDATION."}]},"Ratings":{"Mission Deployment Rate":{"score":1.2},"Program Expense Ratio":{"score":1.0},"Fundraising Efficiency":{"score":null,"percentile":null},"Filing Consistency Score":{"score":0.9230769230769231},"Grant Itemization Coverage":{"score":null},"Independent Voting Board Pct":{"score":null},"Operating Margin":{"score":-29.287142857142857,"percentile":0.012977323749082588},"Operating Reserve Ratio":{"score":null,"percentile":null},"Liabilities to Assets Ratio":{"score":null,"percentile":null},"Officer Compensation Ratio":{"score":null,"percentile":null},"Program Expense Growth":{"score":null,"percentile":null},"Revenue Growth":{"score":-1.1432586698953557,"percentile":0.005406151141227277},"Asset Growth":{"score":null,"percentile":null},"Foreign Oversight Score":{"score":null},"Major-Donor Itemization":{"score":null},"Related-Party Transparency":{"score":null},"Pay-Setting Controls":{"score":1.0,"weight":5,"atoms":{"Compensation committee":{"value":true},"Independent compensation consultant":{"value":true},"Form 990 of other organizations reviewed":{"value":true},"Written employment contract":{"value":true},"Compensation survey or study":{"value":true},"Board or committee approval":{"value":true}}},"Governance Policy Score":{"score":null,"weight":5,"atoms":{"Conflict of interest policy":{"value":null},"Whistle blower policy":{"value":null},"Document retention policy":{"value":null},"Compensation process for CEO":{"value":null},"Compensation process for other employees":{"value":null},"Form 990 provided to governing body":{"value":null},"Minutes of governing body":{"value":null},"Audit committee":{"value":null},"Independent audit financial statements":{"value":null}}},"Categories":{"Financial Efficiency":{"score":1.135135135135135,"weight":45},"Transparency & Controls":{"score":0.9505494505494506,"weight":20},"Accountability":{"score":null,"weight":14},"Sustainability":{"score":0.012977323749082588,"weight":13},"Growth":{"score":0.005406151141227277,"weight":8}},"Overall Score":{"score":0.817488657092302,"percentile":0.7374348870236904}},"source_xml":"201303409349200100_public.xml"},"sector":"Health","donation_categories":[],"zakat_policy":null},"error":null}